EN/CN

About Us

Great Bay Bio (GBB) is a Hong Kong-based high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies in CMC bioprocessing, ultimately solving numerous pain-points of biopharmaceutical industry, including high failure rates, long development timeline and high costs. Since the company’s establishment, it has accumulated massive bioprocessing development data from its 3100 m2 CMC facility, which bolster advance equipment from world-renowned manufacturers. GBB has also successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created an intelligent centralized database, where deep learning is being performed to create a next generation, all-encompassing AI-enabled bioprocessing ecosystem. GBB has a...

Learn More

What We Do

AI Enabled Biotechnology Development Platform

Learn More

Klone4.0TM

AI-enabled Cell Line Development Platform

Obtaining High Producers Actively and Accurately

AlfaStaX®

AI-enabled Cell Line Stability Prediction Platform

Cell lines stability at 90 days can be predicted at 15 days

AlfaMedX®

AI-enabled Culture Media Development Platform

Providing Customized Media Formulation Faster at Lower Cost

News

Partners

  • (+852)3102 3232